Global Topotecan Market Growth (Status and Outlook) 2025-2031

December 2025 | 99 pages | ID: GDB3685D1C4EN
LP Information

Abstracts

According to this study, the global Topotecan market size will reach US$ million by 2031.

Topotecan (trade name Hycamtin) is a chemotherapeutic agent that is a topoisomerase inhibitor. It is a synthetic, water-soluble analog of the natural chemical compound camptothecin. It is used in the form of its hydrochloride salt to treat ovarian cancer, lung cancer and other cancer types.

United States market for Topotecan is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Topotecan is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Topotecan is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Topotecan players cover GSK, Teva, Fresenius Kabi, Cipla, Sagent Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Topotecan Industry Forecast” looks at past sales and reviews total world Topotecan sales in 2024, providing a comprehensive analysis by region and market sector of projected Topotecan sales for 2025 through 2031. With Topotecan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Topotecan industry.

This Insight Report provides a comprehensive analysis of the global Topotecan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Topotecan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Topotecan market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Topotecan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Topotecan.

This report presents a comprehensive overview, market shares, and growth opportunities of Topotecan market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Capsules
• Injection

Segmentation by Application:

• Ovarian Cancer
• Lung Cancer
• Other Cancer types

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GSK
• Teva
• Fresenius Kabi
• Cipla
• Sagent Pharmaceuticals
• Mylan
• Pfizer
• Dr. Reddy's Laboratories

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Topotecan Market Size (2020-2031)
  2.1.2 Topotecan Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Topotecan by Country/Region (2020, 2024 & 2031)
2.2 Topotecan Segment by Type
  2.2.1 Capsules
  2.2.2 Injection
2.3 Topotecan Market Size by Type
  2.3.1 Topotecan Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Topotecan Market Size Market Share by Type (2020-2025)
2.4 Topotecan Segment by Application
  2.4.1 Ovarian Cancer
  2.4.2 Lung Cancer
  2.4.3 Other Cancer types
2.5 Topotecan Market Size by Application
  2.5.1 Topotecan Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Topotecan Market Size Market Share by Application (2020-2025)

3 TOPOTECAN MARKET SIZE BY PLAYER

3.1 Topotecan Market Size Market Share by Player
  3.1.1 Global Topotecan Revenue by Player (2020-2025)
  3.1.2 Global Topotecan Revenue Market Share by Player (2020-2025)
3.2 Global Topotecan Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 TOPOTECAN BY REGION

4.1 Topotecan Market Size by Region (2020-2025)
4.2 Global Topotecan Annual Revenue by Country/Region (2020-2025)
4.3 Americas Topotecan Market Size Growth (2020-2025)
4.4 APAC Topotecan Market Size Growth (2020-2025)
4.5 Europe Topotecan Market Size Growth (2020-2025)
4.6 Middle East & Africa Topotecan Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Topotecan Market Size by Country (2020-2025)
5.2 Americas Topotecan Market Size by Type (2020-2025)
5.3 Americas Topotecan Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Topotecan Market Size by Region (2020-2025)
6.2 APAC Topotecan Market Size by Type (2020-2025)
6.3 APAC Topotecan Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Topotecan Market Size by Country (2020-2025)
7.2 Europe Topotecan Market Size by Type (2020-2025)
7.3 Europe Topotecan Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Topotecan by Region (2020-2025)
8.2 Middle East & Africa Topotecan Market Size by Type (2020-2025)
8.3 Middle East & Africa Topotecan Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL TOPOTECAN MARKET FORECAST

10.1 Global Topotecan Forecast by Region (2026-2031)
  10.1.1 Global Topotecan Forecast by Region (2026-2031)
  10.1.2 Americas Topotecan Forecast
  10.1.3 APAC Topotecan Forecast
  10.1.4 Europe Topotecan Forecast
  10.1.5 Middle East & Africa Topotecan Forecast
10.2 Americas Topotecan Forecast by Country (2026-2031)
  10.2.1 United States Market Topotecan Forecast
  10.2.2 Canada Market Topotecan Forecast
  10.2.3 Mexico Market Topotecan Forecast
  10.2.4 Brazil Market Topotecan Forecast
10.3 APAC Topotecan Forecast by Region (2026-2031)
  10.3.1 China Topotecan Market Forecast
  10.3.2 Japan Market Topotecan Forecast
  10.3.3 Korea Market Topotecan Forecast
  10.3.4 Southeast Asia Market Topotecan Forecast
  10.3.5 India Market Topotecan Forecast
  10.3.6 Australia Market Topotecan Forecast
10.4 Europe Topotecan Forecast by Country (2026-2031)
  10.4.1 Germany Market Topotecan Forecast
  10.4.2 France Market Topotecan Forecast
  10.4.3 UK Market Topotecan Forecast
  10.4.4 Italy Market Topotecan Forecast
  10.4.5 Russia Market Topotecan Forecast
10.5 Middle East & Africa Topotecan Forecast by Region (2026-2031)
  10.5.1 Egypt Market Topotecan Forecast
  10.5.2 South Africa Market Topotecan Forecast
  10.5.3 Israel Market Topotecan Forecast
  10.5.4 Turkey Market Topotecan Forecast
10.6 Global Topotecan Forecast by Type (2026-2031)
10.7 Global Topotecan Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Topotecan Forecast

11 KEY PLAYERS ANALYSIS

11.1 GSK
  11.1.1 GSK Company Information
  11.1.2 GSK Topotecan Product Offered
  11.1.3 GSK Topotecan Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 GSK Main Business Overview
  11.1.5 GSK Latest Developments
11.2 Teva
  11.2.1 Teva Company Information
  11.2.2 Teva Topotecan Product Offered
  11.2.3 Teva Topotecan Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Teva Main Business Overview
  11.2.5 Teva Latest Developments
11.3 Fresenius Kabi
  11.3.1 Fresenius Kabi Company Information
  11.3.2 Fresenius Kabi Topotecan Product Offered
  11.3.3 Fresenius Kabi Topotecan Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Fresenius Kabi Main Business Overview
  11.3.5 Fresenius Kabi Latest Developments
11.4 Cipla
  11.4.1 Cipla Company Information
  11.4.2 Cipla Topotecan Product Offered
  11.4.3 Cipla Topotecan Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Cipla Main Business Overview
  11.4.5 Cipla Latest Developments
11.5 Sagent Pharmaceuticals
  11.5.1 Sagent Pharmaceuticals Company Information
  11.5.2 Sagent Pharmaceuticals Topotecan Product Offered
  11.5.3 Sagent Pharmaceuticals Topotecan Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Sagent Pharmaceuticals Main Business Overview
  11.5.5 Sagent Pharmaceuticals Latest Developments
11.6 Mylan
  11.6.1 Mylan Company Information
  11.6.2 Mylan Topotecan Product Offered
  11.6.3 Mylan Topotecan Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Mylan Main Business Overview
  11.6.5 Mylan Latest Developments
11.7 Pfizer
  11.7.1 Pfizer Company Information
  11.7.2 Pfizer Topotecan Product Offered
  11.7.3 Pfizer Topotecan Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Pfizer Main Business Overview
  11.7.5 Pfizer Latest Developments
11.8 Dr. Reddy's Laboratories
  11.8.1 Dr. Reddy's Laboratories Company Information
  11.8.2 Dr. Reddy's Laboratories Topotecan Product Offered
  11.8.3 Dr. Reddy's Laboratories Topotecan Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Dr. Reddy's Laboratories Main Business Overview
  11.8.5 Dr. Reddy's Laboratories Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Topotecan Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Topotecan Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players of Injection
Table 5. Topotecan Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Topotecan Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Topotecan Market Size Market Share by Type (2020-2025)
Table 8. Topotecan Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Topotecan Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Topotecan Market Size Market Share by Application (2020-2025)
Table 11. Global Topotecan Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Topotecan Revenue Market Share by Player (2020-2025)
Table 13. Topotecan Key Players Head office and Products Offered
Table 14. Topotecan Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Topotecan Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Topotecan Market Size Market Share by Region (2020-2025)
Table 19. Global Topotecan Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Topotecan Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Topotecan Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Topotecan Market Size Market Share by Country (2020-2025)
Table 23. Americas Topotecan Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Topotecan Market Size Market Share by Type (2020-2025)
Table 25. Americas Topotecan Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Topotecan Market Size Market Share by Application (2020-2025)
Table 27. APAC Topotecan Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Topotecan Market Size Market Share by Region (2020-2025)
Table 29. APAC Topotecan Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Topotecan Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Topotecan Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Topotecan Market Size Market Share by Country (2020-2025)
Table 33. Europe Topotecan Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Topotecan Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Topotecan Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Topotecan Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Topotecan Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Topotecan
Table 39. Key Market Challenges & Risks of Topotecan
Table 40. Key Industry Trends of Topotecan
Table 41. Global Topotecan Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Topotecan Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Topotecan Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Topotecan Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. GSK Details, Company Type, Topotecan Area Served and Its Competitors
Table 46. GSK Topotecan Product Offered
Table 47. GSK Topotecan Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. GSK Main Business
Table 49. GSK Latest Developments
Table 50. Teva Details, Company Type, Topotecan Area Served and Its Competitors
Table 51. Teva Topotecan Product Offered
Table 52. Teva Topotecan Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Teva Main Business
Table 54. Teva Latest Developments
Table 55. Fresenius Kabi Details, Company Type, Topotecan Area Served and Its Competitors
Table 56. Fresenius Kabi Topotecan Product Offered
Table 57. Fresenius Kabi Topotecan Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Fresenius Kabi Main Business
Table 59. Fresenius Kabi Latest Developments
Table 60. Cipla Details, Company Type, Topotecan Area Served and Its Competitors
Table 61. Cipla Topotecan Product Offered
Table 62. Cipla Topotecan Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Cipla Main Business
Table 64. Cipla Latest Developments
Table 65. Sagent Pharmaceuticals Details, Company Type, Topotecan Area Served and Its Competitors
Table 66. Sagent Pharmaceuticals Topotecan Product Offered
Table 67. Sagent Pharmaceuticals Topotecan Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Sagent Pharmaceuticals Main Business
Table 69. Sagent Pharmaceuticals Latest Developments
Table 70. Mylan Details, Company Type, Topotecan Area Served and Its Competitors
Table 71. Mylan Topotecan Product Offered
Table 72. Mylan Topotecan Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. Mylan Main Business
Table 74. Mylan Latest Developments
Table 75. Pfizer Details, Company Type, Topotecan Area Served and Its Competitors
Table 76. Pfizer Topotecan Product Offered
Table 77. Pfizer Topotecan Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. Pfizer Main Business
Table 79. Pfizer Latest Developments
Table 80. Dr. Reddy's Laboratories Details, Company Type, Topotecan Area Served and Its Competitors
Table 81. Dr. Reddy's Laboratories Topotecan Product Offered
Table 82. Dr. Reddy's Laboratories Topotecan Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Dr. Reddy's Laboratories Main Business
Table 84. Dr. Reddy's Laboratories Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Topotecan Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Topotecan Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Topotecan Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Topotecan Sales Market Share by Country/Region (2024)
Figure 8. Topotecan Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Topotecan Market Size Market Share by Type in 2024
Figure 10. Topotecan in Ovarian Cancer
Figure 11. Global Topotecan Market: Ovarian Cancer (2020-2025) & ($ millions)
Figure 12. Topotecan in Lung Cancer
Figure 13. Global Topotecan Market: Lung Cancer (2020-2025) & ($ millions)
Figure 14. Topotecan in Other Cancer types
Figure 15. Global Topotecan Market: Other Cancer types (2020-2025) & ($ millions)
Figure 16. Global Topotecan Market Size Market Share by Application in 2024
Figure 17. Global Topotecan Revenue Market Share by Player in 2024
Figure 18. Global Topotecan Market Size Market Share by Region (2020-2025)
Figure 19. Americas Topotecan Market Size 2020-2025 ($ millions)
Figure 20. APAC Topotecan Market Size 2020-2025 ($ millions)
Figure 21. Europe Topotecan Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Topotecan Market Size 2020-2025 ($ millions)
Figure 23. Americas Topotecan Value Market Share by Country in 2024
Figure 24. United States Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Topotecan Market Size Market Share by Region in 2024
Figure 29. APAC Topotecan Market Size Market Share by Type (2020-2025)
Figure 30. APAC Topotecan Market Size Market Share by Application (2020-2025)
Figure 31. China Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 35. India Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Topotecan Market Size Market Share by Country in 2024
Figure 38. Europe Topotecan Market Size Market Share by Type (2020-2025)
Figure 39. Europe Topotecan Market Size Market Share by Application (2020-2025)
Figure 40. Germany Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 41. France Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Topotecan Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Topotecan Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Topotecan Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Topotecan Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Topotecan Market Size 2026-2031 ($ millions)
Figure 54. APAC Topotecan Market Size 2026-2031 ($ millions)
Figure 55. Europe Topotecan Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Topotecan Market Size 2026-2031 ($ millions)
Figure 57. United States Topotecan Market Size 2026-2031 ($ millions)
Figure 58. Canada Topotecan Market Size 2026-2031 ($ millions)
Figure 59. Mexico Topotecan Market Size 2026-2031 ($ millions)
Figure 60. Brazil Topotecan Market Size 2026-2031 ($ millions)
Figure 61. China Topotecan Market Size 2026-2031 ($ millions)
Figure 62. Japan Topotecan Market Size 2026-2031 ($ millions)
Figure 63. Korea Topotecan Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Topotecan Market Size 2026-2031 ($ millions)
Figure 65. India Topotecan Market Size 2026-2031 ($ millions)
Figure 66. Australia Topotecan Market Size 2026-2031 ($ millions)
Figure 67. Germany Topotecan Market Size 2026-2031 ($ millions)
Figure 68. France Topotecan Market Size 2026-2031 ($ millions)
Figure 69. UK Topotecan Market Size 2026-2031 ($ millions)
Figure 70. Italy Topotecan Market Size 2026-2031 ($ millions)
Figure 71. Russia Topotecan Market Size 2026-2031 ($ millions)
Figure 72. Egypt Topotecan Market Size 2026-2031 ($ millions)
Figure 73. South Africa Topotecan Market Size 2026-2031 ($ millions)
Figure 74. Israel Topotecan Market Size 2026-2031 ($ millions)
Figure 75. Turkey Topotecan Market Size 2026-2031 ($ millions)
Figure 76. Global Topotecan Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Topotecan Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Topotecan Market Size 2026-2031 ($ millions)